CENTER ON BEHAVIORAL MEDICINE
Disease: Research Article
Berlin, I., Lemonine, A., et al. (2004). Should Major Depression
with 'High Normal' Thyroid-Stimulating Hormone Be Treated
with Tricyclics? Neuropsychobiology; 50, 2.
ABSTRACT: In a prospective and naturalistic setting, two samples representing 209 depressed inpatients were assessed for thyroid functioning at admission before antidepressant treatment, and for depression before and after 1 month of antidepressant treatment. We hypothesized that se-rum thyroid-stimulating hormone (TSH) elevation >_ up-per 25th percentile of the normal reference range is associated with poorer response to antidepressant therapy and differences between tricyclic antidepressants (TCA) and other antidepressants. Screening for mild thyroid failure defined as serum TSH concentrations >_ upper 25th percentile of the normal range may provide clues to the clinician. Such patients have a more severe form of depression and a slower or impaired response to antidepressant therapy. It is also possible that they would benefit preferentially from TCA rather than other antidepressants.
1 Howland RH: Thyroid dysfunction in refractory depression: Implication for pathophysiology and treatment. J Clin Psychiatry 1993;54:47-54.
2 Altshuler LL, Bauer M, Frye MA, Gitlin MJ, Mintz J, Szuba MP, Leight KL, Whybrow PC: Does thyroid supplementation accelerate tricyclic antidepressant response? A review and meta-analysis of the literature. Am J Psychiatry 2001;158:1617-1622.
3 Nemeroff CB: Clinical significance of psychoneuroendocrinology in psychiatry: Focus on the thyroid and adrenal. J Clin Psychiatry 1989;50(suppl):13-20.
4 Berlin I, Payan C, Corruble E, Puech AJ: Se-rum thyroid stimulating hormone concentration as an index of severity of major depression. Int J Neuropsychopharmacol 1999;2: 105-110.
5 Concato J, Shah N, Horwitz RI: Randomized controlled trials, observational studies and the hierarchy of research designs. N Engl J Med 2000;342:1887-1892.
6 Benson K, Hartz AJ: A comparison of observational studies and randomized, controlled trials. N Engl J Med 2000;342:1878-1886.
7 Khan A, Brown W: The placebo enigma in anti-depressant clinical trials. J Clin Psychopharmacol 2001;21:123-125.
8 Schatzberg AF, Kraemer HC: Use of placebo control groups in evaluating efficacy of treatment of unipolar major depression. Biol Psychiatry 2000;47:736-744.
9 Zimmerman M, Mattia JI, Posternak MA: Are subjects in pharmacological treatment trials of depression representative of patients in routine clinical practice? Am J Psychiatry 2002;159: 469-473.
10 Sheehan DV, Lecrubier Y, Harnett Sheehan K, Amorim P, Janavs J, Weiller E, Hergueta T, Baker R, Dunbar G: The Mini International Neuropsychiatric Interview (M.I.N.I.): The development and validation of a structured diagnostic psychiatric interview. J Clin Psychiatry 1998;59(520):22-33.
11 Montgomery S, Asberg M: A new scale de-signed to be sensitive to change. Br J Psychiatry 1979;134:382-389.
12 Hamilton M: A rating scale for
J Neurol Neurosurg Psychiatry 1960;23:56-62.